Sort
82,697 grants matching “vaccine development”
Vectored HIV Immunotherapy via in vivo B cell editing
$1,272,001David T Curiel · Washington University · R01 · FY2025 · AI
Synthesis and Evaluation of Carbohydrate Vaccine Adjuvants
$1,271,476Hien M Nguyen · Wayne State University · R01 · FY2025 · AI
Scientific Research Support Component E/ Data Management
$1,271,407Adam Godzik · Scripps Research Institute, The · UM1 · FY2014 · AI
Immune Reconstitution
$1,271,094Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Protein-mediated membrane remodeling
$1,271,050Leonid V. Chernomordik · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD
HUMAN MELANOMA--ETIOLOGY, PROGRESSION AND THERAPY
$1,271,012Wistar Institute · P01 · FY2000 · CA
GLOBAL HIV VACCINE ENTERPRISE
$1,270,842Bill Snow · Global Hiv Vaccine Enterprise · N01 · FY2012 · AI
Monoclonal antibody isolation and characterization
$1,270,555Rosemarie Mason · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
LOS ANGELES PEDIATRIC AIDS CONSORTIUM
$1,270,551University Of California Los Angeles · U01 · FY2001 · AI
The Atlantic Coast Sexually Transmitted Infection Cooperative Research Center (AC
$1,270,480Ann E. Jerse · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2016 · AI
SAN FRANCISCO HIV VACCINE CLINICAL TRAILS UNIT
$1,270,283Public Health Foundation Enterprises · U01 · FY2000 · AI
Entry and replication of positive-sense, RNA viruses
$1,270,265Joseph Marcotrigiano · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Structural characterization of OM proteins from Gram-negative pathogens
$1,270,075Susan Buchanan · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
DEVELOPMENT OF PERSONALIZED CANCER VACCINES TARGETING TUMOR HETEROGENEITY AND REPROGRAMMING THE COLD TUMOR MICRO-ENVIRONMENT IN KIDNEY CANCER
$1,270,020The General Hospital Corporation · · FY2025 · Defense Health Agency
Mechanisms Of Humoral Evasion
$1,269,871Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
B-cell biology scientific research support component
$1,269,612Garnett H Kelsoe · Duke University · UM1 · FY2017 · AI
Development of furanones for treatment of anthrax
$1,269,383New York University School Of Medicine · R01 · FY2005 · AI
Mechanisms of Effective Humoral Immune Responses to HIV-1
$1,268,948Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,268,948Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Acute Hepatitis C Infection in Young Injectors
$1,268,832Kimberly Page · University Of New Mexico Health Scis Ctr · R01 · FY2018 · DA
Therapeutic antibody for RSV
$1,268,751Lawrence Michael Kauvar · Trellis Bioscience, Inc. · R44 · FY2016 · AI
Mucosal Immunology and Virology
$1,268,609Neeltje Van Doremalen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Producing Polyclonal Human Antibodies to Anthrax
$1,268,537Hematech, Llc · R44 · FY2005 · AI
Molecular Genetics Of Scrapie Pathogenesis
$1,268,450Suzette Alise Priola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
CLINICAL EPIDEMIOLOGY &PATHOGENESIS OF ASYMPTOMATIC HSV
$1,268,198Fred Hutchinson Cancer Research Center · P01 · FY2002 · AI